Thanapirom, K., Suksawatamnuay, S., Sukeepaisarnjareon, W., Tanwandee, T., Charatcharoenwitthaya, P., Thongsawat, S., . . . Komolmit, P. (2018). Genetic variation in the Vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter study.
Chicago Style CitationThanapirom, Kessarin, et al. Genetic Variation in the Vitamin D Pathway CYP2R1 Gene Predicts Sustained HBeAg Seroconversion in Chronic Hepatitis B Patients Treated With Pegylated Interferon: A Multicenter Study. 2018.
MLA CitationThanapirom, Kessarin, et al. Genetic Variation in the Vitamin D Pathway CYP2R1 Gene Predicts Sustained HBeAg Seroconversion in Chronic Hepatitis B Patients Treated With Pegylated Interferon: A Multicenter Study. 2018.